HIV-1 Genotypic Drug Resistance Mutation Analysis, Plasma
Fees Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.
Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.
This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.
CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
87901-HIV-1 genotypic drug resistance
LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.
|Result ID||Reporting Name||LOINC Code|
|82340||HIV-1 Genotypic Drug Resistance, P||30554-0|
|21395||Reverse Transcriptase Mutations||30554-0|
|28076||Atazanavir with Ritonavir||49618-2|
|26784||Darunavir with Ritonavir||49630-7|
|26733||Fosamprenavir with Ritonavir||51409-1|
|26734||Indinavir with Ritonavir||49619-0|
|21532||Lopinavir with Ritonavir||42000-0|
|26735||Saquinavir with Ritonavir||49621-6|
|28201||Tipranavir with Ritonavir||49622-4|
LOINC and CPT codes are provided by the performing laboratory.